Profile data is unavailable for this security.
About the company
Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
- Revenue in NOK (TTM)23.95m
- Net income in NOK-36.30m
- LocationArctic Bioscience ASIndustrivegen 42ORSTA 6155NorwayNOR
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ABS:OSL since |
|Arctic Algae AS||Deal completed||13 Feb 2023||13 Feb 2023Deal completed||-5.07%||--|